1 History

Brachytherapy developed from early experiments with radioactive materials soon after the discovery of radioactivity. Its evolution reflects broader advances in radiation physics, imaging, and cancer care. Over time, methods changed from relatively crude insertions of radioactive sources to carefully planned treatments designed to maximize tumor dose while protecting nearby tissues.

1.1 Early development

The earliest forms of brachytherapy emerged in the late 19th and early 20th centuries, when physicians began applying radium and other radioactive substances to superficial lesions. Initial uses were often empirical, with treatment times and source strengths based on observation rather than precise dosimetry. Despite limited understanding of long-term effects, these early efforts established the principle of placing radiation close to the target.

1.2 Evolution of radioactive implants

As cancer therapy matured, radioactive materials were incorporated into needles, seeds, tubes, and applicators for more controlled delivery. This allowed treatment of deeper tumors and improved reproducibility. The development of standardized source encasement, dose measurement, and shielding made implants safer and more practical. In parallel, permanent seed implantation became an important approach for select cancers, especially where localized, sustained radiation was desirable.

1.3 Modern image-guided techniques

Contemporary brachytherapy increasingly relies on imaging to define anatomy and guide source placement. Ultrasound, computed tomography, magnetic resonance imaging, and other modalities help clinicians position applicators and estimate dose with much greater precision than earlier methods. These image-guided techniques have expanded treatment options, improved conformality, and reduced exposure to normal tissues.

2 Principles of brachytherapy

Brachytherapy works by placing a radioactive source inside a body cavity, within tissue, or adjacent to the tumor. Because the radiation travels only a short distance, the dose falls off rapidly with distance from the source. This physical property is central to both its therapeutic value and its technical requirements.

2.1 Radiation delivery

Radiation may be delivered through temporary placement of a source for a defined period or through permanent implantation of small radioactive seeds. Temporary treatments commonly use afterloading systems, in which the source is introduced after the applicator has been positioned. This reduces occupational exposure and permits accurate control of source dwell time and position.

2.2 Dose distribution

The dose pattern in brachytherapy is highly localized and steeply shaped. Tissue nearest the source receives the highest exposure, while dose decreases quickly beyond the target region. This can allow escalation of tumor dose without proportionally increasing radiation to surrounding organs. However, the same characteristic makes precise placement essential, since small positional errors can affect both tumor coverage and normal tissue sparing.

2.3 Advantages and limitations

A major advantage of brachytherapy is its ability to deliver intense treatment directly to the target. It may shorten overall treatment time and, in some settings, preserve organ function better than other radiation approaches. Limitations include the need for specialized expertise, invasive procedures, and careful imaging and planning. Not all tumors are suitable for this method, particularly when disease extent is diffuse or anatomy makes source placement difficult.

3 Types of brachytherapy

Brachytherapy can be classified by treatment duration, source position, and the route used to access the target. The method selected depends on tumor location, size, shape, and clinical intent.

3.1 Temporary brachytherapy

Temporary brachytherapy involves placing a radioactive source for a limited interval and then removing it. This approach is widely used because it allows flexible dose delivery and can be adapted to different treatment schedules.

3.1.1 High-dose-rate brachytherapy

High-dose-rate brachytherapy delivers radiation over a short period, often in outpatient or brief procedural settings. A remote afterloading machine advances the source into the applicator for a programmed time. This technique is efficient and allows precise modulation of source position, making it suitable for many gynecologic, prostate, breast, and head and neck applications.

3.1.2 Low-dose-rate brachytherapy

Low-dose-rate brachytherapy exposes tissue to radiation continuously over many hours or days at a lower intensity. It was used extensively in earlier treatment eras and still has selected indications. Because the source remains in place for longer intervals, this method often requires more protective measures and, in some cases, inpatient management.

3.2 Permanent brachytherapy

Permanent brachytherapy uses sealed radioactive seeds that remain in the body after implantation. The seeds gradually lose activity over time. This approach is especially common in localized prostate cancer and some other cancers where a sustained, confined dose is advantageous. The implants are usually small and may be arranged in a grid or pattern to cover the target volume.

3.3 Intracavitary brachytherapy

Intracavitary brachytherapy places the source within a natural body cavity, such as the uterus, vagina, or esophagus. Applicators are designed to fit the anatomy and position the source close to the tumor bed or mucosal surface. This method is especially valuable for cancers arising in or near hollow organs.

3.4 Interstitial brachytherapy

Interstitial brachytherapy inserts needles, catheters, or seeds directly into tissue. It is used when the tumor is embedded in an organ or soft tissue and cannot be adequately treated from inside a cavity. Because source placement can be adapted to the tumor geometry, this technique offers strong conformality.

3.5 Intraluminal brachytherapy

Intraluminal brachytherapy places the source within the lumen of a tubular organ, such as the bronchus, bile duct, or esophagus. It is often used to palliate obstruction or treat localized disease lining the organ wall. Dose is delivered close to the mucosa, where tumor burden is frequently concentrated.

3.6 Surface brachytherapy

Surface brachytherapy treats lesions on or near the skin or other accessible surfaces. It uses molds, applicators, or small sources placed externally against the lesion. This method is useful for superficial cancers and certain benign conditions requiring localized radiation.

4 Clinical uses

Brachytherapy is used in a range of malignancies, either as definitive treatment, as an adjunct to surgery or external beam radiation therapy, or as palliation. Its role is greatest where local control depends on a concentrated dose to a confined target.

4.1 Gynecologic cancers

Gynecologic oncology has long relied on brachytherapy because of the close relationship between tumors and pelvic organs. It is often integrated into multimodality treatment.

4.1.1 Cervical cancer

Cervical cancer is one of the classic indications for brachytherapy. It can deliver a high dose to the cervix and adjacent tissues while limiting exposure to bladder and rectum. In many treatment plans, it is a key component of curative therapy after external beam radiation and chemotherapy.

4.1.2 Endometrial cancer

In endometrial cancer, brachytherapy is commonly used in the vaginal cuff after surgery to reduce local recurrence risk. In selected cases, it may also be part of treatment for more advanced or recurrent disease. The technique is valued for its ability to concentrate dose in the operative bed.

4.2 Prostate cancer

Prostate cancer is a major indication for permanent seed implantation and, in some centers, temporary high-dose-rate therapy. Brachytherapy can serve as primary treatment for localized disease or as a boost combined with external beam radiation. It is often chosen for patients seeking high local control with limited irradiation of nearby organs.

4.3 Breast cancer

In breast cancer, brachytherapy may be used after breast-conserving surgery, especially to treat the lumpectomy cavity. This approach can shorten treatment courses compared with whole-breast irradiation in selected patients. It is also used in some partial-breast irradiation strategies.

4.4 Head and neck cancers

Head and neck tumors may be treated with interstitial or intracavitary brachytherapy depending on site and extent. The method is particularly useful when a localized boost is needed near complex anatomy. It can help preserve speech, swallowing, or other functions when carefully planned.

4.5 Skin cancer

Superficial skin cancers and some recurrences are amenable to surface brachytherapy. This technique can be especially helpful for lesions in cosmetically sensitive areas where surgery might produce a less favorable result. Treatment molds can be shaped to the contour of the lesion for improved dose distribution.

4.6 Other malignancies

Brachytherapy has additional uses in cancers of the esophagus, bronchus, bile ducts, and soft tissues. It may also be applied in selected recurrent tumors or in situations where resection is not feasible. The choice of technique depends on tumor accessibility and the surrounding anatomy.

5 Treatment planning

Successful brachytherapy depends on careful planning before source placement. Planning balances tumor coverage, organ protection, and practical considerations such as applicator geometry and treatment time.

5.1 Imaging for localization

Imaging identifies the tumor extent and surrounding anatomy. Modalities such as ultrasound, computed tomography, and magnetic resonance imaging help determine where to place applicators and how the source should be arranged. Good localization is especially important for irregular or poorly defined lesions.

5.2 Target volume definition

Clinicians define the target volume by accounting for visible disease, microscopic extension, and expected movement or deformation. The planned treatment region may differ from the tumor seen on imaging alone. Clear target definition reduces the risk of underdosing disease or overdosing nearby structures.

5.3 Source placement

Source placement is selected to match the shape and depth of the target. Needles, catheters, or applicators may be inserted under imaging or direct visualization. Accurate spacing and orientation are essential, since a small change in placement can alter dose distribution.

5.4 Dose calculation

Dose calculation estimates how much radiation each part of the target and adjacent tissue will receive. Modern planning systems use source geometry, dwell positions, and tissue information to generate treatment maps. These calculations support individualized treatment and help ensure that clinical goals are met.

5.5 Fractionation schedules

Fractionation refers to how the total dose is divided over time. Some treatments use a single session, while others are spread over multiple fractions. The schedule depends on tumor type, source type, and normal tissue tolerance, as well as logistical factors and institutional practice.

6 Procedure

The brachytherapy procedure typically involves preparation, placement of the applicator or source pathway, radiation delivery, and completion of treatment. The exact sequence depends on whether the source is temporary or permanent.

6.1 Patient preparation

Preparation may include imaging, review of prior treatments, anesthesia or sedation planning, and instructions about bladder, bowel, or skin care. Patients are assessed for suitability and for any conditions that might increase procedural risk. Informed consent addresses the invasive nature of the treatment and possible side effects.

6.2 Applicator or catheter placement

An applicator, catheter, or needle system is positioned to reach the target precisely. Placement may occur in an operating room, procedure suite, or radiation oncology department. Imaging or endoscopic guidance is often used to verify location and symmetry.

6.3 Source delivery

For temporary brachytherapy, the radioactive source is introduced after the applicator has been secured. The source remains in the treatment position for the planned interval and may move between preset dwell locations. Remote afterloading systems are commonly used to reduce staff exposure and improve control.

6.4 Treatment completion and source removal

When treatment ends, temporary sources are withdrawn and applicators are removed. The patient is then monitored for immediate effects such as bleeding, discomfort, or urinary or bowel symptoms depending on the site treated. Discharge instructions usually include activity guidance and warning signs that require medical attention.

6.5 Permanent implant follow-up

After permanent implantation, the seeds remain in place and the body gradually emits less radiation as radioactive decay occurs. Follow-up may include imaging to assess seed distribution and clinical evaluation for treatment response and toxicity. Patients are often given instructions regarding small residual radiation exposure to others, especially in the early period after implantation.

7 Safety and radiation protection

Radiation safety is a central part of brachytherapy practice. Because sources are placed near the patient and, in some cases, remain present for a period of time, institutions use specific measures to protect staff, patients, and visitors.

7.1 Staff precautions

Personnel follow shielding, time, and distance principles to minimize exposure. Remote afterloading reduces the need for direct handling of active sources. Staff training, procedural checklists, and controlled access to treatment areas are standard elements of safe practice.

7.2 Patient isolation and visitor restrictions

Some treatments, especially certain low-dose-rate procedures, may require limited contact or restricted room access. Visitor policies depend on the source type and exposure level. Clear communication helps patients and families understand temporary precautions without undue concern.

7.3 Exposure monitoring

Facilities may use dosimeters and environmental monitoring to track radiation exposure. Source accountability, inventory control, and documentation are important components of quality assurance. These measures help confirm that source placement and retrieval are complete and accurate.

7.4 Emergency procedures

Emergency protocols address source displacement, applicator malfunction, and unexpected patient movement. Staff are trained to recognize and respond to these events quickly. Rapid source retrieval and verification procedures are essential to prevent unnecessary exposure or treatment interruption.

8 Side effects and complications

Adverse effects vary by treatment site, dose, technique, and whether radiation is combined with other therapies. Many effects are temporary, but some can persist or appear later.

8.1 Acute effects

Short-term reactions may include pain, swelling, fatigue, skin irritation, urinary frequency, bowel discomfort, or mucosal inflammation, depending on the location treated. Acute effects often begin during treatment or shortly afterward and usually improve with supportive care.

8.2 Late effects

Late complications can develop months or years after treatment. These may include fibrosis, tissue narrowing, dryness, scarring, or chronic irritation. The likelihood of late toxicity is influenced by total dose, fractionation, and nearby organ sensitivity.

8.3 Organ-specific complications

Complications differ by site. Pelvic treatment can affect bladder, rectum, or vaginal tissues; prostate treatment may cause urinary or sexual dysfunction; head and neck treatment can impair swallowing or salivary function; and thoracic or esophageal treatment may produce local inflammation or narrowing. Careful planning aims to limit these risks.

Problems may arise from applicator displacement, seed migration, infection, bleeding, or incomplete source removal. Most are uncommon when procedures are performed under experienced supervision. Postprocedure verification helps detect and manage technical issues promptly.

9 Outcomes

Treatment outcomes depend on cancer type, stage, dose, technique, and whether brachytherapy is used alone or in combination with other modalities. In many settings, it contributes substantially to local disease control.

9.1 Local control

Brachytherapy is often effective at controlling disease in the treated region because it delivers a concentrated dose directly to the target. Local control is especially strong when lesions are well localized and source placement is accurate. This is one reason the method remains important in several curative regimens.

9.2 Survival outcomes

Overall survival depends on more than local treatment alone, including tumor biology and the presence of spread beyond the primary site. Brachytherapy can support survival by improving local control and, in some cancers, by contributing to definitive therapy. Its benefit is most pronounced when integrated into appropriate multimodal treatment.

9.3 Quality of life

By limiting dose to nearby normal tissue, brachytherapy may preserve function and reduce treatment duration. Patients may experience advantages in convenience, recovery, or organ preservation compared with more extensive radiation approaches. However, quality-of-life outcomes are influenced by side effects, procedural burden, and individual cancer site.

9.4 Comparative effectiveness

Comparisons with surgery, external beam radiation therapy, and combined regimens depend on the disease being treated. In some settings, brachytherapy offers superior local dose delivery; in others, it serves as a boost or alternative for selected patients. Decisions are typically individualized based on anatomy, tumor characteristics, and therapeutic goals.

10 Special considerations

Certain clinical situations require adaptation of standard brachytherapy methods. Age, prior treatment, and symptom relief goals may all influence selection of technique.

10.1 Pediatric use

Brachytherapy in children is less common than in adults but may be used for selected tumors. Planning must account for growth, organ sensitivity, and the need to minimize late effects. Specialized multidisciplinary care is usually required.

10.2 Reirradiation

Brachytherapy can sometimes be used in previously irradiated areas because its steep dose falloff may spare adjacent tissues better than broader-field techniques. This use requires careful review of prior doses and close attention to cumulative toxicity. It is generally reserved for selected recurrent tumors.

10.3 Combination with other therapies

Brachytherapy is often combined with surgery, external beam radiation therapy, chemotherapy, or hormonal therapy depending on the cancer type. The sequence of treatments is chosen to optimize tumor control and reduce complications. Multidisciplinary planning is especially important when multiple modalities are used.

10.4 Palliative brachytherapy

In palliative care, brachytherapy may relieve bleeding, obstruction, pain, or other local symptoms. The aim is symptom control rather than cure, and treatment courses are often shorter or simplified. Its focused action can provide rapid benefit in appropriately selected patients.

</INTERNAL_LINK_CANDIDATES> Radioactive source (a sealed emitter of radiation used in treatment) Afterloading (a method that inserts the source after applicator placement) Dosimetry (the measurement and calculation of radiation dose) Applicator (a device that positions the source near the target) Seed implant (a permanent placement of small radioactive pellets) Interstitial therapy (radiation delivered directly into tissue) Intracavitary therapy (radiation delivered within a body cavity) Intraluminal therapy (radiation delivered within a tubular organ) Surface therapy (radiation delivered to superficial lesions) External beam radiation therapy (radiation delivered from outside the body) Image-guided therapy (planning and delivery assisted by imaging) Fractionation (dividing treatment into multiple sessions) Local control (prevention of tumor regrowth in the treated area) Quality of life (overall physical and functional well-being after treatment) Reirradiation (treatment of a previously irradiated area) Palliative care (symptom-focused treatment without curative intent) Gynecologic oncology (cancer care for the female reproductive system) Prostate cancer (a common indication for seed implantation) Cervical cancer (a classic use of brachytherapy in the pelvis) Tumor localization (identifying the exact position of disease) </INTERNAL_LINK_CANDIDATES>